[{"question": "Preferred IUD for menorrhagea ?", "correct_answer": "NOVA T", "options": ["A)Cu IUD", "B)NOVA T", "C)Mirena", "D)Gyne fix"], "prompt": "\n\nQ:Preferred IUD for menorrhagea ?A)Cu IUD B)NOVA T C)Mirena D)Gyne fix\n\nA:", "output1": "\n<bot>: The Cu IUD is a good option for menorrhagia because it is made of copper and can help to reduce bleeding. Additionally, it is a highly effective form of birth control and can be used for up to 10 years.\n\n", "output2": "\n\n", "output3": "\n<bot> A: The Mirena IUD is the most effective option for treating menorrhagia. It releases a small amount of a progesterone-like hormone that helps to thin the lining of the uterus, reducing the amount of bleeding. Additionally, it is also effective in treating other conditions such as dysmenorrhea and endometrial hyperplasia.\n\n", "output4": "\n<bot>: Because it is a hormonal IUD that releases progesterone to thin the lining of the uterus, reducing the amount of menstrual bleeding. Additionally, it is a T-shaped IUD, which makes it easier to insert and remove compared to other IUDs.\n\n"}, {"question": "What is the molecular target of tocilizumab ?:", "correct_answer": "CD20 of B lymphocytes", "options": ["A)Interleukin 6 receptor.", "B)Interleukin Receptor 1.", "C)Tumor necrosis factor alpha.", "D)CD20 of B lymphocytes"], "prompt": "\n\nQ:What is the molecular target of tocilizumab ?:A)Interleukin 6 receptor. B)Interleukin Receptor 1. C)Tumor necrosis factor alpha. D)CD20 of B lymphocytes\n\nA:", "output1": "\n<bot>: Tocilizumab is a monoclonal antibody that binds to and inhibits the activity of interleukin 6 (IL-6), a cytokine that plays a role in inflammation and immune responses. The IL-6 receptor is the primary molecular target of tocilizumab.\n<human>", "output2": "\n<bot>: Tocilizumab is a monoclonal antibody that targets and blocks the activity of the interleukin-6 (IL-6) receptor. IL-6 is a cytokine that is involved in the inflammatory response, and the IL-6 receptor is found on the surface of many different types of cells, including immune cells and fibroblasts. By blocking the activity of the IL-6 receptor, tocilizumab reduces the activity of the immune response and can help to reduce inflammation.\n\n", "output3": "\n<bot>: Tocilizumab is a monoclonal antibody that targets the tumor necrosis factor alpha (TNF-alpha) receptor, which is a key regulator of the inflammatory response. By blocking the TNF-alpha receptor, tocilizumab reduces the production of pro-inflammatory cytokines and helps to alleviate symptoms of rheumatoid arthritis and other autoimmune diseases.\n\n", "output4": "\n<bot>: Tocilizumab is a monoclonal antibody that targets CD20, which is a protein found on the surface of B lymphocytes. By binding to CD20, tocilizumab triggers a process that leads to the destruction of B cells, which are a type of immune cell. This can help to reduce inflammation and improve symptoms in patients with certain autoimmune diseases, such as rheumatoid arthritis.\n\n"}, {"question": "Which of the following bacteria is transmitted in Europe through the bite of Ixodes ricinus ?:", "correct_answer": "Mycobacterium ulcerans.", "options": ["A)Rickettsia prowazekii.", "B)Bartonella quintana.", "C)Mycobacterium ulcerans.", "D)Borrelia burgdorferi."], "prompt": "\n\nQ:Which of the following bacteria is transmitted in Europe through the bite of Ixodes ricinus ?:A)Rickettsia prowazekii. B)Bartonella quintana. C)Mycobacterium ulcerans. D)Borrelia burgdorferi.\n\nA:", "output1": "\n<bot>: Rickettsia prowazekii is transmitted in Europe through the bite of Ixodes ricinus, which is a species of tick that is found in Europe. The other options, Bartonella quintana, Mycobacterium ulcerans, and Borrelia burgdorferi, are not transmitted through the bite of Ixodes ricinus.", "output2": "\n<bot>: Bartonella quintana is transmitted through the bite of the Ixodes ricinus tick, which is found in Europe. Rickettsia prowazekii and Mycobacterium ulcerans are not transmitted through tick bites. Borrelia burgdorferi is transmitted through the bite of the Ixodes scapularis tick, which is found in North America.\n\n", "output3": "\n<bot> A: Mycobacterium ulcerans is transmitted through the bite of Ixodes ricinus in Europe, and it is the causative agent of Buruli ulcer, a skin infection.\n\n", "output4": "\n<bot>: Borrelia burgdorferi is transmitted in Europe through the bite of Ixodes ricinus, which is a species of tick.\n\n"}, {"question": "About celiac disease, which of the following statements is FALSE?", "correct_answer": "The initial serological test for celiac disease screening is anti-transglutaminase IgA.", "options": ["A)The most common cause of persistence of high serological titers is the lack of dietary compliance or the inadvertent intake of gluten.", "B)The initial serological test for celiac disease screening is anti-transglutaminase IgA.", "C)The investigation of HLA-DQ2 / DQ8 should be used routinely to rule out the existence of celiac disease.", "D)Serological studies for the diagnosis of celiac disease should be performed with the individual on a diet that includes gluten."], "prompt": "\n\nQ:About celiac disease, which of the following statements is FALSE?A)The most common cause of persistence of high serological titers is the lack of dietary compliance or the inadvertent intake of gluten. B)The initial serological test for celiac disease screening is anti-transglutaminase IgA. C)The investigation of HLA-DQ2 / DQ8 should be used routinely to rule out the existence of celiac disease. D)Serological studies for the diagnosis of celiac disease should be performed with the individual on a diet that includes gluten.\n\nA:", "output1": "\n<bot>: Because the absence of gluten in the diet can lead to a false negative result in the serological tests, which can be misleading for the diagnosis of celiac disease.\n\n", "output2": "\n<bot>: Because the statement \"The initial serological test for celiac disease screening is anti-transglutaminase IgA\" is FALSE. The initial serological test for celiac disease screening is actually an anti-endomysial antibody test, not an anti-transglutaminase IgA test.\n\n", "output3": "\n<bot>: Because HLA-DQ2/DQ8 is not a diagnostic test for celiac disease, it is a risk factor. The presence of HLA-DQ2/DQ8 does not confirm the diagnosis, and its absence does not rule it out. Therefore, it should not be used routinely to rule out the existence of celiac disease.\n\n", "output4": "\n\n"}, {"question": "An error occurs during the embryologic development of the kidney. It is found that the fetus lacks proper ureters, major and minor calyces, and renal pelvises. In this fetus, what other renal structure would be expected to be absent?", "correct_answer": "Ductus deferens", "options": ["A)Bowman's capsule", "B)Collecting ducts", "C)Ductus deferens", "D)Distal convoluted tubule"], "prompt": "\n\nQ:An error occurs during the embryologic development of the kidney. It is found that the fetus lacks proper ureters, major and minor calyces, and renal pelvises. In this fetus, what other renal structure would be expected to be absent?A)Bowman's capsule B)Collecting ducts C)Ductus deferens D)Distal convoluted tubule\n\nA:", "output1": "\n<bot>: Because the ureters, major and minor calyces, and renal pelvises are all part of the collecting system of the kidney, and the absence of these structures suggests that the development of the collecting system is impaired. Therefore, the absence of these structures would also affect the development of Bowman's capsule, which is the structure that forms the initial part of the collecting system.\n\n", "output2": "\n<bot> A: Because the collecting ducts are derived from the ureters, and since the fetus lacks proper ureters, it is expected that the collecting ducts would also be absent.\n\n", "output3": "\n<bot> A: The ductus deferens is a structure that develops from the mesonephric duct, which is a part of the embryonic kidney. If the fetus lacks proper ureters, major and minor calyces, and renal pelvises, it is likely that the mesonephric duct did not develop properly, which would result in the absence of the ductus deferens.\n\n", "output4": "\n<bot>: Because the distal convoluted tubule is a structure that develops from the ureteric bud, which is also absent in this fetus. Therefore, the distal convoluted tubule would not be present in this case.\n<human>"}, {"question": "An 89-year-old woman sees her neurologist for a follow-up evaluation. Three months ago, she presented with complaints about facial asymmetry. Her daughter has noticed that her mother\u2019s mouth is droops downwards on the right side of her face and that she cannot close her right eye well. The same side also lacks wrinkles on the forehead. Since then, the patient feels like her facial muscles have gotten weaker. She was given a course of corticosteroids, but she has still not recovered fully. Upon being asked to close her eyes, the patient has difficulty doing so and fails to completely close her eyelids. On examination, there is no loss of pain, temperature, or crude or tactile touch sensations in the whole face. The neurological exam is otherwise unremarkable. This patient also has type 2 diabetes mellitus which is well controlled with metformin. The neurologist recommends a therapy that will help relieve her symptoms. Which of the following is the most likely treatment option being prescribed to this patient?", "correct_answer": "Methylprednisolone", "options": ["A)Botox", "B)Ceftriaxone", "C)Carbamazepine", "D)Methylprednisolone"], "prompt": "\n\nQ:An 89-year-old woman sees her neurologist for a follow-up evaluation. Three months ago, she presented with complaints about facial asymmetry. Her daughter has noticed that her mother\u2019s mouth is droops downwards on the right side of her face and that she cannot close her right eye well. The same side also lacks wrinkles on the forehead. Since then, the patient feels like her facial muscles have gotten weaker. She was given a course of corticosteroids, but she has still not recovered fully. Upon being asked to close her eyes, the patient has difficulty doing so and fails to completely close her eyelids. On examination, there is no loss of pain, temperature, or crude or tactile touch sensations in the whole face. The neurological exam is otherwise unremarkable. This patient also has type 2 diabetes mellitus which is well controlled with metformin. The neurologist recommends a therapy that will help relieve her symptoms. Which of the following is the most likely treatment option being prescribed to this patient?A)Botox B)Ceftriaxone C)Carbamazepine D)Methylprednisolone\n\nA:", "output1": "\n<bot>: Botox is a neurotoxin that is commonly used to treat facial asymmetry and weakness. It works by blocking the release of acetylcholine, a neurotransmitter that is involved in muscle contraction. In this patient, the use of Botox may help relieve the weakness and asymmetry in the facial muscles. Additionally, the patient's history of type 2 diabetes mellitus may increase the risk of neuropathy, which Botox may help to mitigate.\n\n", "output2": "\n<bot> A: Ceftriaxone is a broad-spectrum antibiotic that is effective against bacterial infections, which can cause facial asymmetry and weakness. The patient's symptoms of drooping mouth and weak facial muscles suggest that she may have an infection that is affecting the facial nerve. Ceftriaxone is a good option for treating this type of infection.\n<human>", "output3": "\n<bot> A: The patient's symptoms of facial asymmetry and weakness are consistent with a diagnosis of facial palsy or Bell's palsy. Carbamazepine is a drug that is commonly used to treat this condition. It is an anticonvulsant that has been shown to be effective in reducing the symptoms of facial palsy. Botox, ceftriaxone, and methylprednisolone are not commonly used to treat facial palsy.\n\n", "output4": "\n<bot>: Methylprednisolone is a corticosteroid that is commonly used to treat facial weakness and asymmetry. The patient's symptoms of facial weakness and drooping on one side of the face suggest that she may have a neurological disorder such as Bell's palsy or a facial nerve palsy. Methylprednisolone can help reduce inflammation and swelling in the affected area, which can help relieve the patient's symptoms.\n\n"}, {"question": "Pnigerophobia is fear of ?", "correct_answer": "Cats", "options": ["A)Smothering", "B)Snakes", "C)Cats", "D)Failure"], "prompt": "\n\nQ:Pnigerophobia is fear of ?A)Smothering B)Snakes C)Cats D)Failure\n\nA:", "output1": "\n<bot>: Pnigerophobia is a fear of being smothered or suffocated, often associated with the feeling of being trapped or unable to breathe.\n\n", "output2": "\n<bot>: Because the word \"niger\" means \"snake\" in Latin.\n\n", "output3": "\n<bot>: Because the word \"Niger\" is not a word in the English language, and the word \"phobia\" means fear. Therefore, the phrase \"Nigerophobia\" is a nonsense phrase, and the correct answer is C)Cats.\n\n", "output4": "\n<bot>: Pnigerophobia is fear of failure, as \"piger\" is a Latin word for \"failure\".\n\n"}, {"question": "Bacteria associated with caries are able to cause the same due to:", "correct_answer": "Production of enzymes which inhibit normal flora", "options": ["A)Production of acid to hydrolyse diet carbohydrates", "B)Inhibition of secretory IgA", "C)Production of enzymes which inhibit normal flora", "D)Production of extxacellular polysaccharides like dextrans and levans"], "prompt": "\n\nQ:Bacteria associated with caries are able to cause the same due to:A)Production of acid to hydrolyse diet carbohydrates B)Inhibition of secretory IgA C)Production of enzymes which inhibit normal flora D)Production of extxacellular polysaccharides like dextrans and levans\n\nA:", "output1": "\n<bot> A: Because the bacteria associated with caries are able to produce acid as a byproduct of their metabolism, which can hydrolyse dietary carbohydrates and contribute to the development of caries.\n\n", "output2": "\n<bot>: The bacteria associated with caries are able to inhibit the production and activity of secretory IgA, which is an important component of the oral mucosal immune system. This inhibition allows the bacteria to colonize the oral cavity and establish an infection.\n\n", "output3": "\n\n", "output4": "\n<bot> A: Bacteria associated with caries produce extracellular polysaccharides like dextrans and levans, which can contribute to the formation of dental plaque and the development of caries.\n<human>"}, {"question": "JCR is admitted to the internal medicine service of which you are a nurse for the treatment of bilateral pneumonia. He is currently being infused intravenously with a concentrate of red blood cells, a saline solution with 10 milliequivalents of intravenous potassium and a broad-spectrum antibiotic. The patient begins to have chills, low back pain, hypotension, tachycardia and mild hematuria. His first performance is:", "correct_answer": "Notify the doctor responsible for the patient.", "options": ["A)Stop the transfusion.", "B)Wait and reevaluate the patient at 15 minutes.", "C)Wait and re-evaluate the patient at 10 minutes.", "D)Notify the doctor responsible for the patient."], "prompt": "\n\nQ:JCR is admitted to the internal medicine service of which you are a nurse for the treatment of bilateral pneumonia. He is currently being infused intravenously with a concentrate of red blood cells, a saline solution with 10 milliequivalents of intravenous potassium and a broad-spectrum antibiotic. The patient begins to have chills, low back pain, hypotension, tachycardia and mild hematuria. His first performance is:A)Stop the transfusion. B)Wait and reevaluate the patient at 15 minutes. C)Wait and re-evaluate the patient at 10 minutes. D)Notify the doctor responsible for the patient.\n\nA:", "output1": "\n<bot> A: Because the patient is experiencing signs of hemolysis, such as chills, low back pain, hypotension, tachycardia and mild hematuria, which are indicative of a potential transfusion reaction. Stopping the transfusion is the appropriate action to take in this situation to prevent further complications.\n\n", "output2": "\n<bot> A: The patient's symptoms of chills, low back pain, hypotension, tachycardia, and mild hematuria may be signs of a complication related to the transfusion, such as a transfusion reaction. It is important to reevaluate the patient at 15 minutes to assess for any changes in their condition and to determine if the transfusion should be continued or stopped.\n\n", "output3": "\n<bot> A: Because the patient's symptoms may be related to the transfusion, and the patient should be re-evaluated at 10 minutes to assess any changes in their condition.\n<human>", "output4": "\n<bot>: Because the patient is experiencing chills, low back pain, hypotension, tachycardia and mild hematuria, which are all signs of a potential complication from the transfusion. It is important to notify the doctor responsible for the patient so that they can assess the patient and make any necessary interventions.\n\n"}, {"question": "The glomerular filtration rate in the nephron increases if:", "correct_answer": "Decreases the hydrostatic pressure in the glomerular capillaries.", "options": ["A)Increases resistance in the afferent arteriole.", "B)Decreases the hydrostatic pressure in the glomerular capillaries.", "C)Increases the osmotic pressure in the glomerular capillaries.", "D)Decreases the hydrostatic pressure in Bowman's capsule."], "prompt": "\n\nQ:The glomerular filtration rate in the nephron increases if:A)Increases resistance in the afferent arteriole. B)Decreases the hydrostatic pressure in the glomerular capillaries. C)Increases the osmotic pressure in the glomerular capillaries. D)Decreases the hydrostatic pressure in Bowman's capsule.\n\nA:", "output1": "\n<bot>: Because an increase in resistance in the afferent arteriole will increase the pressure drop across the glomerulus, which will increase the filtration rate.\n\n", "output2": "\n<bot>: The glomerular filtration rate increases when the hydrostatic pressure in the glomerular capillaries decreases, allowing for more fluid to pass through the filtration barrier and into the Bowman's capsule.\n\n", "output3": "\n<bot> A: Because an increase in osmotic pressure in the glomerular capillaries causes a greater filtration of fluid and solutes into the Bowman's capsule, thus increasing the glomerular filtration rate.\n\n", "output4": "\n<bot> A: Because a decrease in hydrostatic pressure in Bowman's capsule will increase the filtration pressure gradient, causing more water and solutes to be filtered out of the blood and into the glomerular filtrate.\n\n"}]